US
Almost half of US physicians will prescribe more biosimilars, according to survey
March 4, 2016Medical Communications Obama, US, biosimilar, patent, prescribing
New data published by InCrowd has suggested that US physicians are very amenable to the prescription of biosimilars, with some …
Big pharma answers tough questions at US drug pricing hearing
February 5, 2016Medical Communications Drug pricing, FDA, Martin Shkreli, Senate, Turing Pharmaceuticals, US, Valeant, congress
Pharmaceutical industry executives came under intense scrutiny at a Congressional hearing in the US as the debate over the spiralling …
Big pharma joins President Obama’s cancer ‘moonshot’
January 13, 2016Research and Development Amgen, Cancer, Celgene, National Immunotherapy Coalition, President Barack Obama, US, moonshot
Celgene and Amgen are among the large biopharma companies that have agreed to join the National Immunotherapy Coalition (NIC), a …
Obama government launches drug price crackdown
November 4, 2015Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, President Obama, US, affordability, market access
President Obama has launched an ‘Affordable Drug Pricing Task Force’, aimed at tackling the spiralling cost of certain prescription medications …
Recall after mislabelling of Medline Industries’ drugs
October 20, 2015Manufacturing and Production US, acetaminophen, paracetamol, product recall
Medline Industries is voluntarily carrying out a nationwide recall of the painkiller acetaminophen, due to a labelling error on the …
Valeant receives court writ over US drug pricing
October 15, 2015Medical Communications, Sales and Marketing Drug pricing, Isuprel, Nitropress, US, Valeant, subpoena
Valeant Pharmaceuticals has disclosed that it has received two subpoenas in the US, demanding evidence concerning the pricing and distribution …
Hilary Clinton’s pharma ‘enemies’ amongst her biggest financial supporters
October 14, 2015Drug pricing, Hilary Clinton, US, pricing reform
Hilary Clinton’s plans to make waging war with pharma companies a central plank of her US presidential campaign have been …
AstraZeneca purchases former Amgen US facility
September 15, 2015Manufacturing and Production Amgen, AstraZeneca, US, biologics, manufacturing, production
AstraZeneca has bolstered its US presence with the purchase of a high-tech biologics manufacturing facility from pharma rival Amgen. The …
FDA approves Lundbeck and Otsuka’s Rexulti for depression
July 14, 2015Sales and Marketing FDA, Lundbeck, Otsuka, Rexulti, US, brexpiprazole, depression, major depressive disorder, schizophrenia
Lundbeck and Otsuka have gained a yes vote from the FDA for their jointly-marketed antidepressant, Rexulti. The US regulator approved …
Pharma ‘paid US doctors $1.5 billion’ in 2014
July 7, 2015Medical Communications, Sales and Marketing Sunshine Act, US, pharma
Some of the largest European drugmakers paid US doctors and teaching hospitals $1.5 billion in 2014 to participate in promotional …
Teva moves to buy Mylan
April 21, 2015Research and Development, Sales and Marketing India, Mylan, Perrigo, Teva, US, Vigodman, generics, israel, merger
Israeli generics drug giant Teva has made an offer to buy its US rival Mylan for around $40.1 billion. The …
Merck seeks new Keytruda indication in US
April 20, 2015Sales and Marketing Cancer, FDA, NSCLC, PD-L1, US, keytruda, lung, pembrolizumab
Merck is seeking FDA approval for its successful melanoma drug Keytruda to be used treating lung cancer. The Supplemental Biologics …
FDA grants AstraZeneca immune drug orphan status
April 15, 2015Sales and Marketing AstraZeneca, FDA, Iressa, MEDI4736, MedImmune, NSCLC, US, gefitinib, non-small cell lung cancer, tremelimumab
The US Food and Drug Administration has granted orphan drug designation to AstraZeneca’s anti-CTLA-4 monoclonal antibody tremelimumab for the treatment …
US drug spend soars to all-time high in 2014
April 14, 2015Manufacturing and Production, Sales and Marketing Lipitor, Obama, UK Health and Social Care Information Centre, US, drug spend, prescribing
The number of prescriptions dispensed in the US rose by 13% in 2014 a new report has shown. The increase …
Eisai cuts 25% of US staff
April 10, 2015Medical Communications, Research and Development, Sales and Marketing Daiichi, Eisai, US, cuts, layoffs, reorganisation, staff
Eisai’s US business is offloading around 200 jobs as part of some restructuring to create a more ‘efficient and focussed …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
